Macroaxis Story

Today I will concentrate on 8 Compulsion isntruments to have in your portfolio in September 2019. I will cover Constellation Brands, Lindsay Corporation, Anheuser Busch Inbev SA Sponsor, Bristol Myers Squibb Company, Merck Company, Astrazeneca PLC, Philip Morris International, and British American Tobacco Indus
Published over a year ago
View all stories for Macroaxis | View All Stories
The Top 8 Compulsion stocks to own in September 2019

This list of potential positions covers Addiction driven consumer products and services. Companies involved in research, development, and manufacturing of products with compulsion characteristics such as cigarettes, addictive drugs and alcohol in USA. Please note, we provide buy hold or sell recommendation only in the context of selected investment horizon assuming investor has average attitude towards taking risk. Please also consider using Portfolio Positions Ratings and Equity Ratings tools to further calibrate your research.

Story appears to be empty

Constellation Brands (STZ)

Constellation Brands has Return on Asset of 6.11 % which means that on every $100 spent on asset, it made $6.11 of profit. This is considered to be average in the sector. In the same way, it shows return on shareholders equity (ROE) of 0.72 %, implying that it generated $0.72 on every 100 dollars invested. Constellation Brands management efficiency ratios could be used to measure of how well the company is managing its routine affairs as well as how well it utilizes its assets and manages liabilities. Return on Investment is likely to rise to 8.55 in 2020, whereas Return on Average Assets are likely to drop (0.0428)  in 2020. Constellation Brands Total Assets are fairly stable at the moment as compared to the past year. Constellation Brands reported Total Assets of 27.32 Billion in 2019. Assets Non Current is likely to rise to about 13.6 B in 2020, whereas Current Assets are likely to drop slightly above 3 B in 2020. The entity currently falls under 'Large-Cap' category with total capitalization of 36.3 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Constellation Brands's market, we take the total number of its shares issued and multiply it by Constellation Brands's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. Constellation Brands shows a prevailing Real Value of $176.92 per share. The current price of the firm is $181.87. At this time, the firm appears to be fairly valued. Our model approximates the value of Constellation Brands from analyzing the firm fundamentals such as Current Valuation of 48.3 B, return on equity of 0.72 %, and Profit Margin of 0.68 % as well as examining its technical indicators and Probability Of Bankruptcy. In general, we favor acquiring undervalued instruments and dropping overvalued instruments since, at some point, asset prices and their ongoing real values will blend.

Lindsay (LNN)

Lindsay has Return on Asset of 4.8 % which means that on every $100 spent on asset, it made $4.8 of profit. This is considered to be average in the sector. In the same way, it shows return on shareholders equity (ROE) of 9.2 %, implying that it generated $9.2 on every 100 dollars invested. Lindsay management efficiency ratios could be used to measure of how well the company is managing its routine affairs as well as how well it utilizes its assets and manages liabilities. Return on Investment is expected to rise to 1.82 this year. Return on Average Assets is expected to rise to 0.003695 this year. Lindsay Return on Average Assets are quite stable at the moment as compared to the past year. The company's current value of Return on Average Assets is estimated at 0.003695The entity currently falls under 'Mid-Cap' category with total capitalization of 1.03 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Lindsay's market, we take the total number of its shares issued and multiply it by Lindsay's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

  Total Debt

114.36 Million
Lindsay Total Debt is quite stable at the moment as compared to the past year. The company's current value of Total Debt is estimated at 114.36 Million

Anheuser Busch Inbev (BUD)

Anheuser Busch Inbev has Return on Asset of 2.76 % which means that on every $100 spent on asset, it made $2.76 of profit. This is way below average. In the same way, it shows return on shareholders equity (ROE) of (0.22) %, meaning that it generated no profit with money invested by stockholders. Anheuser Busch management efficiency ratios could be used to measure of how well the company is managing its routine affairs as well as how well it utilizes its assets and manages liabilities. Anheuser Busch Return on Average Equity is projected to slightly decrease based on the last few years of reporting. The past year's Return on Average Equity was at 0.12. The current year Return on Invested Capital is expected to grow to 0.14, whereas Return on Sales is forecasted to decline to 0.30. Anheuser Busch Return on Average Assets are projected to slightly decrease based on the last few years of reporting. The past year's Return on Average Assets were at 0.037This firm currently falls under 'Mega-Cap' category with total capitalization of 107.4 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Anheuser Busch's market, we take the total number of its shares issued and multiply it by Anheuser Busch's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. Anheuser Busch Inbev shows a prevailing Real Value of $53.64 per share. The current price of the firm is $52.88. At this time, the firm appears to be fairly valued. Our model approximates the value of Anheuser Busch Inbev from analyzing the firm fundamentals such as profit margin of 2.54 %, and Return On Equity of (0.22) % as well as examining its technical indicators and Probability Of Bankruptcy. In general, we favor purchasing undervalued instruments and exiting overvalued instruments since, at some point, asset prices and their ongoing real values will blend.

Bristol Myers Squibb (BMY)

Bristol Myers Squibb has Return on Asset of 5.16 % which means that on every $100 spent on asset, it made $5.16 of profit. This is considered to be average in the sector. In the same way, it shows return on shareholders equity (ROE) of (1.65) %, meaning that it generated no profit with money invested by stockholders. Bristol Myers management efficiency ratios could be used to measure of how well the company is managing its routine affairs as well as how well it utilizes its assets and manages liabilities. Return on Investment is likely to rise to 15.40 in 2020. Return on Average Assets is likely to rise to 0.07 in 2020. Bristol Myers Total Assets are fairly stable at the moment as compared to the past year. Bristol Myers reported Total Assets of 129.94 Billion in 2019. Assets Non Current is likely to rise to about 108.5 B in 2020, whereas Current Assets are likely to drop slightly above 24.5 B in 2020. This firm currently falls under 'Mega-Cap' category with total capitalization of 133.59 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Bristol Myers's market, we take the total number of its shares issued and multiply it by Bristol Myers's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

  Total Debt

50.42 Billion
Bristol Myers Total Debt is fairly stable at the moment as compared to the past year. Bristol Myers reported Total Debt of 46.73 Billion in 2019

Merck Company (MRK)

Merck Inc has Return on Asset of 11.19 % which means that on every $100 spent on asset, it made $11.19 of profit. This is considered to be average in the sector. In the same way, it shows return on shareholders equity (ROE) of 37.85 %, implying that it generated $37.85 on every 100 dollars invested. Merck management efficiency ratios could be used to measure of how well the company is managing its routine affairs as well as how well it utilizes its assets and manages liabilities. Merck Return on Investment is increasing as compared to previous years. The last year's value of Return on Investment was reported at 22.30. The current Return on Average Assets is estimated to increase to 0.13, while Return on Average Equity is projected to decrease to 0.29. The current Total Liabilities is estimated to increase to about 61.3 B. The current Current Liabilities is estimated to increase to about 22.3 BThe entity currently falls under 'Mega-Cap' category with total capitalization of 217.03 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Merck's market, we take the total number of its shares issued and multiply it by Merck's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. Merck Inc secures a last-minute Real Value of $83.75 per share. The latest price of the firm is $83.15. At this time, the firm appears to be fairly valued. Our model forecasts the value of Merck Inc from analyzing the firm fundamentals such as Current Valuation of 233.53 B, profit margin of 22.20 %, and Return On Equity of 37.85 % as well as examining its technical indicators and Probability Of Bankruptcy. In general, we recommend purchasing undervalued stocks and trading away overvalued stocks since, at some point, asset prices and their ongoing real values will merge together.

Astrazeneca PLC (AZN)

Astrazeneca PLC has Return on Asset of 4.47 % which means that on every $100 spent on asset, it made $4.47 of profit. This is considered to be average in the sector. In the same way, it shows return on shareholders equity (ROE) of 14.24 %, implying that it generated $14.24 on every 100 dollars invested. Astrazeneca PLC management efficiency ratios could be used to measure of how well the company is managing its routine affairs as well as how well it utilizes its assets and manages liabilities. Return on Investment is expected to rise to 9.64 this year. Return on Average Assets is expected to rise to 0.0205 this year. Astrazeneca PLC Asset Turnover is quite stable at the moment as compared to the past year. The company's current value of Asset Turnover is estimated at 0.41. Return on Average Assets is expected to rise to 0.0205 this year, although the value of Tax Assets will most likely fall to about 2.6 B. The entity currently falls under 'Mega-Cap' category with total capitalization of 144.91 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Astrazeneca PLC's market, we take the total number of its shares issued and multiply it by Astrazeneca PLC's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

  Total Debt

17.39 Billion
Astrazeneca PLC Total Debt is quite stable at the moment as compared to the past year. The company's current value of Total Debt is estimated at 17.39 Billion

Philip Morris International (PM)

Philip Morris Intern has Return on Asset (ROA) of 17.35 % which means that for every $100 of asset, it generated profit of $17.35. This is typical in the industry. Philip Morris management efficiency ratios could be used to measure of how well the company is managing its routine affairs as well as how well it utilizes its assets and manages liabilities. Philip Morris Return on Investment is relatively stable at the moment as compared to the past year. The company's current value of Return on Investment is estimated at 65.17. Return on Average Assets is expected to hike to 20.93 this year, although the value of Return on Average Equity will most likely fall to 347.89. Philip Morris Return on Average Assets are relatively stable at the moment as compared to the past year. The company's current value of Return on Average Assets is estimated at 20.93The firm currently falls under 'Mega-Cap' category with market capitalization of 119.93 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Philip Morris's market, we take the total number of its shares issued and multiply it by Philip Morris's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. Philip Morris Intern holds a recent Real Value of $83.08 per share. The prevailing price of the company is $76.35. At this time, the company appears to be undervalued. Our model determines the value of Philip Morris Intern from analyzing the company fundamentals such as Shares Outstanding of 1.56 B, operating margin of 40.94 %, and Return On Equity of 0.0003 % as well as examining its technical indicators and Probability Of Bankruptcy. In general, we support acquiring undervalued entities and dropping overvalued entities since, at some point, asset prices and their ongoing real values will merge together.

British American Tobacco (BTI)

British American Tob has Return on Asset of 4.64 % which means that on every $100 spent on asset, it made $4.64 of profit. This is considered to be average in the sector. In the same way, it shows return on shareholders equity (ROE) of 9.62 %, implying that it generated $9.62 on every 100 dollars invested. British Amer management efficiency ratios could be used to measure of how well the company is managing its routine affairs as well as how well it utilizes its assets and manages liabilities. The current Return on Investment is estimated to increase to 8.33. The current Return on Average Assets is estimated to increase to 0.0411. British Amer Revenue to Assets are most likely to slightly decrease in the upcoming years. The last year's value of Revenue to Assets was reported at 0.18. The current Total Assets Per Share is estimated to increase to 66.56, while Assets Non Current are projected to decrease to roughly 127.4 B. This firm currently falls under 'Large-Cap' category with total capitalization of 78.48 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate British Amer's market, we take the total number of its shares issued and multiply it by British Amer's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

  Total Debt

47.3 Billion
British Amer Total Debt is most likely to increase significantly in the upcoming years. The last year's value of Total Debt was reported at 45.37 Billion

Current Compulsion Recommendations


How important is Macroaxis's Liquidity

Macroaxis financial leverage refers to using borrowed capital as a funding source to finance Macroaxis ongoing operations. It is usually used to expand the firm's asset base and generate returns on borrowed capital. Macroaxis financial leverage is typically calculated by taking the company's all interest-bearing debt and dividing it by total capital. So the higher the debt-to-capital ratio (i.e., financial leverage), the riskier the company. Please check the breakdown between Macroaxis's total debt and its cash.

How Macroaxis utilizes its cash?

To perform a cash flow analysis of Macroaxis, investors first need to understand how to read the cash flow statement. A cash flow statement shows the amount of cash Macroaxis is receiving and how much cash it distributes out in a given period. The Macroaxis cash flow statement breaks down these inflows and outflows into different buckets, including operating activities, investing activities, and financing activities. Macroaxis Net Cash Flow from Operations is fairly stable at the moment as compared to the past year. Macroaxis reported Net Cash Flow from Operations of 10.95 Billion in 2019
Story appears to be empty

Constellation Brands (STZ)

Constellation Brands has Return on Asset of 6.11 % which means that on every $100 spent on asset, it made $6.11 of profit. This is considered to be average in the sector. In the same way, it shows return on shareholders equity (ROE) of 0.72 %, implying that it generated $0.72 on every 100 dollars invested. Constellation Brands management efficiency ratios could be used to measure of how well the company is managing its routine affairs as well as how well it utilizes its assets and manages liabilities. Return on Investment is likely to rise to 8.55 in 2020, whereas Return on Average Assets are likely to drop (0.0428)  in 2020. Constellation Brands Total Assets are fairly stable at the moment as compared to the past year. Constellation Brands reported Total Assets of 27.32 Billion in 2019. Assets Non Current is likely to rise to about 13.6 B in 2020, whereas Current Assets are likely to drop slightly above 3 B in 2020. The entity currently falls under 'Large-Cap' category with total capitalization of 36.3 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Constellation Brands's market, we take the total number of its shares issued and multiply it by Constellation Brands's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. Constellation Brands shows a prevailing Real Value of $176.92 per share. The current price of the firm is $181.87. At this time, the firm appears to be fairly valued. Our model approximates the value of Constellation Brands from analyzing the firm fundamentals such as Current Valuation of 48.3 B, return on equity of 0.72 %, and Profit Margin of 0.68 % as well as examining its technical indicators and Probability Of Bankruptcy. In general, we favor acquiring undervalued instruments and dropping overvalued instruments since, at some point, asset prices and their ongoing real values will blend.

Lindsay (LNN)

Lindsay has Return on Asset of 4.8 % which means that on every $100 spent on asset, it made $4.8 of profit. This is considered to be average in the sector. In the same way, it shows return on shareholders equity (ROE) of 9.2 %, implying that it generated $9.2 on every 100 dollars invested. Lindsay management efficiency ratios could be used to measure of how well the company is managing its routine affairs as well as how well it utilizes its assets and manages liabilities. Return on Investment is expected to rise to 1.82 this year. Return on Average Assets is expected to rise to 0.003695 this year. Lindsay Return on Average Assets are quite stable at the moment as compared to the past year. The company's current value of Return on Average Assets is estimated at 0.003695The entity currently falls under 'Mid-Cap' category with total capitalization of 1.03 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Lindsay's market, we take the total number of its shares issued and multiply it by Lindsay's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

  Total Debt

114.36 Million
Lindsay Total Debt is quite stable at the moment as compared to the past year. The company's current value of Total Debt is estimated at 114.36 Million

Anheuser Busch Inbev (BUD)

Anheuser Busch Inbev has Return on Asset of 2.76 % which means that on every $100 spent on asset, it made $2.76 of profit. This is way below average. In the same way, it shows return on shareholders equity (ROE) of (0.22) %, meaning that it generated no profit with money invested by stockholders. Anheuser Busch management efficiency ratios could be used to measure of how well the company is managing its routine affairs as well as how well it utilizes its assets and manages liabilities. Anheuser Busch Return on Average Equity is projected to slightly decrease based on the last few years of reporting. The past year's Return on Average Equity was at 0.12. The current year Return on Invested Capital is expected to grow to 0.14, whereas Return on Sales is forecasted to decline to 0.30. Anheuser Busch Return on Average Assets are projected to slightly decrease based on the last few years of reporting. The past year's Return on Average Assets were at 0.037This firm currently falls under 'Mega-Cap' category with total capitalization of 107.4 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Anheuser Busch's market, we take the total number of its shares issued and multiply it by Anheuser Busch's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. Anheuser Busch Inbev shows a prevailing Real Value of $53.64 per share. The current price of the firm is $52.88. At this time, the firm appears to be fairly valued. Our model approximates the value of Anheuser Busch Inbev from analyzing the firm fundamentals such as profit margin of 2.54 %, and Return On Equity of (0.22) % as well as examining its technical indicators and Probability Of Bankruptcy. In general, we favor purchasing undervalued instruments and exiting overvalued instruments since, at some point, asset prices and their ongoing real values will blend.

Bristol Myers Squibb (BMY)

Bristol Myers Squibb has Return on Asset of 5.16 % which means that on every $100 spent on asset, it made $5.16 of profit. This is considered to be average in the sector. In the same way, it shows return on shareholders equity (ROE) of (1.65) %, meaning that it generated no profit with money invested by stockholders. Bristol Myers management efficiency ratios could be used to measure of how well the company is managing its routine affairs as well as how well it utilizes its assets and manages liabilities. Return on Investment is likely to rise to 15.40 in 2020. Return on Average Assets is likely to rise to 0.07 in 2020. Bristol Myers Total Assets are fairly stable at the moment as compared to the past year. Bristol Myers reported Total Assets of 129.94 Billion in 2019. Assets Non Current is likely to rise to about 108.5 B in 2020, whereas Current Assets are likely to drop slightly above 24.5 B in 2020. This firm currently falls under 'Mega-Cap' category with total capitalization of 133.59 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Bristol Myers's market, we take the total number of its shares issued and multiply it by Bristol Myers's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

  Total Debt

50.42 Billion
Bristol Myers Total Debt is fairly stable at the moment as compared to the past year. Bristol Myers reported Total Debt of 46.73 Billion in 2019

Merck Company (MRK)

Merck Inc has Return on Asset of 11.19 % which means that on every $100 spent on asset, it made $11.19 of profit. This is considered to be average in the sector. In the same way, it shows return on shareholders equity (ROE) of 37.85 %, implying that it generated $37.85 on every 100 dollars invested. Merck management efficiency ratios could be used to measure of how well the company is managing its routine affairs as well as how well it utilizes its assets and manages liabilities. Merck Return on Investment is increasing as compared to previous years. The last year's value of Return on Investment was reported at 22.30. The current Return on Average Assets is estimated to increase to 0.13, while Return on Average Equity is projected to decrease to 0.29. The current Total Liabilities is estimated to increase to about 61.3 B. The current Current Liabilities is estimated to increase to about 22.3 BThe entity currently falls under 'Mega-Cap' category with total capitalization of 217.03 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Merck's market, we take the total number of its shares issued and multiply it by Merck's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. Merck Inc secures a last-minute Real Value of $83.75 per share. The latest price of the firm is $83.15. At this time, the firm appears to be fairly valued. Our model forecasts the value of Merck Inc from analyzing the firm fundamentals such as Current Valuation of 233.53 B, profit margin of 22.20 %, and Return On Equity of 37.85 % as well as examining its technical indicators and Probability Of Bankruptcy. In general, we recommend purchasing undervalued stocks and trading away overvalued stocks since, at some point, asset prices and their ongoing real values will merge together.

Astrazeneca PLC (AZN)

Astrazeneca PLC has Return on Asset of 4.47 % which means that on every $100 spent on asset, it made $4.47 of profit. This is considered to be average in the sector. In the same way, it shows return on shareholders equity (ROE) of 14.24 %, implying that it generated $14.24 on every 100 dollars invested. Astrazeneca PLC management efficiency ratios could be used to measure of how well the company is managing its routine affairs as well as how well it utilizes its assets and manages liabilities. Return on Investment is expected to rise to 9.64 this year. Return on Average Assets is expected to rise to 0.0205 this year. Astrazeneca PLC Asset Turnover is quite stable at the moment as compared to the past year. The company's current value of Asset Turnover is estimated at 0.41. Return on Average Assets is expected to rise to 0.0205 this year, although the value of Tax Assets will most likely fall to about 2.6 B. The entity currently falls under 'Mega-Cap' category with total capitalization of 144.91 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Astrazeneca PLC's market, we take the total number of its shares issued and multiply it by Astrazeneca PLC's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

  Total Debt

17.39 Billion
Astrazeneca PLC Total Debt is quite stable at the moment as compared to the past year. The company's current value of Total Debt is estimated at 17.39 Billion

Philip Morris International (PM)

Philip Morris Intern has Return on Asset (ROA) of 17.35 % which means that for every $100 of asset, it generated profit of $17.35. This is typical in the industry. Philip Morris management efficiency ratios could be used to measure of how well the company is managing its routine affairs as well as how well it utilizes its assets and manages liabilities. Philip Morris Return on Investment is relatively stable at the moment as compared to the past year. The company's current value of Return on Investment is estimated at 65.17. Return on Average Assets is expected to hike to 20.93 this year, although the value of Return on Average Equity will most likely fall to 347.89. Philip Morris Return on Average Assets are relatively stable at the moment as compared to the past year. The company's current value of Return on Average Assets is estimated at 20.93The firm currently falls under 'Mega-Cap' category with market capitalization of 119.93 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Philip Morris's market, we take the total number of its shares issued and multiply it by Philip Morris's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. Philip Morris Intern holds a recent Real Value of $83.08 per share. The prevailing price of the company is $76.35. At this time, the company appears to be undervalued. Our model determines the value of Philip Morris Intern from analyzing the company fundamentals such as Shares Outstanding of 1.56 B, operating margin of 40.94 %, and Return On Equity of 0.0003 % as well as examining its technical indicators and Probability Of Bankruptcy. In general, we support acquiring undervalued entities and dropping overvalued entities since, at some point, asset prices and their ongoing real values will merge together.

British American Tobacco (BTI)

British American Tob has Return on Asset of 4.64 % which means that on every $100 spent on asset, it made $4.64 of profit. This is considered to be average in the sector. In the same way, it shows return on shareholders equity (ROE) of 9.62 %, implying that it generated $9.62 on every 100 dollars invested. British Amer management efficiency ratios could be used to measure of how well the company is managing its routine affairs as well as how well it utilizes its assets and manages liabilities. The current Return on Investment is estimated to increase to 8.33. The current Return on Average Assets is estimated to increase to 0.0411. British Amer Revenue to Assets are most likely to slightly decrease in the upcoming years. The last year's value of Revenue to Assets was reported at 0.18. The current Total Assets Per Share is estimated to increase to 66.56, while Assets Non Current are projected to decrease to roughly 127.4 B. This firm currently falls under 'Large-Cap' category with total capitalization of 78.48 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate British Amer's market, we take the total number of its shares issued and multiply it by British Amer's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

  Total Debt

47.3 Billion
British Amer Total Debt is most likely to increase significantly in the upcoming years. The last year's value of Total Debt was reported at 45.37 Billion

Current Compulsion Recommendations

About Contributor

This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Please refer to our Terms of Use for any information regarding our disclosure principles.

Would you like to provide feedback on the content of this article?

You can get in touch with us directly or send us a quick note via email to editors@macroaxis.com

Did you try this?

Run Price Ceiling Movement Now

   

Price Ceiling Movement

Calculate and plot Price Ceiling Movement for different equity instruments
All  Next Launch Module
Check out Stocks Correlation. Please also try Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.